Company · CIK 0001640266 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Voyager Therapeutics, Inc. · VYGR
Insider activity reported against this company. All insider holders · Files at: CLPT. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 11, 2019 AForm 4 → | Jan 17, 9:05 pm EST | Andre TurennePresident & CEO, Director | 96,250 | — | — | 96,250 | — | plan? late |
| Jan 11, 2019 AForm 4 → | Jan 17, 8:51 pm EST | Dinah Sah Ph.D.Chief Scientific Officer | 25,000 | — | — | 163,688 | — | plan? late |
| Jan 11, 2019 AForm 4 → | Jan 17, 8:44 pm EST | Matthew P. OttmerChief Operating Officer | 30,000 | — | — | 30,000 | — | plan? late |
| Jan 11, 2019 AForm 4 → | Jan 17, 8:41 pm EST | Allison DorvalChief Financial Officer | 25,000 | — | — | 26,106 | — | plan? late |
| Sep 19, 2018 JForm 4 → | Sep 19, 5:41 pm EDT | Third Rock Ventures III, L.P. +410% Owner | 1,500,000 | — | — | 6,391,176 | — | plan? |
| Sep 19, 2018 JForm 4 → | Sep 19, 5:36 pm EDT | Mark J LevinDirector, 10% Owner | 1,500,000 | — | — | 6,391,176 | — | plan? |
| Sep 12, 2018 PForm 4 → | Sep 12, 8:49 pm EDT | Glenn PierceDirector | 5,000 | $18.44 | $92,200 | 5,000 | — | plan? |
| Sep 10, 2018 PForm 4 → | Sep 12, 8:49 pm EDT | James A GeraghtyDirector | 3,000 | $19.39 | $58,170 | 76,588 | +4.08% | plan? |
| Aug 17, 2018 PForm 4 → | Aug 21, 4:05 pm EDT | James A GeraghtyDirector | 3,000 | $18.31 | $54,930 | 73,588 | +4.25% | plan? |
| Jun 20, 2018 JForm 4 → | Jun 21, 4:05 pm EDT | Third Rock Ventures III, L.P. +410% Owner | 1,500,000 | — | — | 7,891,176 | — | plan? |
| Jun 20, 2018 JForm 4 → | Jun 21, 4:05 pm EDT | Mark J LevinDirector, 10% Owner | 1,500,000 | — | — | 7,891,176 | — | plan? |
| Apr 10, 2018 SForm 4 → | Apr 12, 4:01 pm EDT | Bernard RavinaChief Medical Officer | 2,451 | $18.38 | $45,049 | 0 | −100% | plan? |
| Mar 22, 2018 SForm 4 → | Mar 26, 4:02 pm EDT | Jane HendersonSr. V.P. & CFO, Corp. Dev. | 31,100 | $20.87 | $649,117 | 0 | −100% | plan? |
| Mar 22, 2018 MForm 4 → | Mar 26, 4:02 pm EDT | Jane HendersonSr. V.P. & CFO, Corp. Dev. | 31,100 | $11.97 | $372,267 | 11,200 | — | plan? |
| Mar 16, 2018 SForm 4 → | Mar 20, 5:43 pm EDT | Jane HendersonCFO & SVP, Corp. Dev. | 17,316 | $22.11 | $382,808 | 0 | −100% | plan? |
| Mar 16, 2018 MForm 4 → | Mar 20, 5:43 pm EDT | Jane HendersonCFO & SVP, Corp. Dev. | 17,316 | $11.97 | $207,273 | 1,900 | — | plan? |
| Mar 12, 2018 SForm 4 → | Mar 14, 4:07 pm EDT | Bernard RavinaChief Medical Officer | 2,451 | $25.16 | $61,667 | 2,451 | −50.0% | plan? |
| Feb 27, 2018 SForm 4 → | Mar 1, 6:00 pm EST | Dinah Sah Ph.D.Chief Scientific Officer | 15,623 | $30.00 | $468,690 | 138,688 | −10.1% | plan? |
| Feb 27, 2018 MForm 4 → | Mar 1, 6:00 pm EST | Dinah Sah Ph.D.Chief Scientific Officer | 15,623 | $9.98 | $155,845 | 154,311 | — | plan? |
| Feb 12, 2018 SForm 4 → | Feb 13, 4:10 pm EST | Bernard RavinaChief Medical Officer | 2,451 | $18.24 | $44,706 | 4,902 | −33.3% | plan? |
| Jan 10, 2018 SForm 4 → | Jan 12, 8:57 am EST | Bernard RavinaChief Medical Officer | 3,630 | $16.40 | $59,532 | 7,353 | −33.1% | plan? |
| Dec 11, 2017 SForm 4 → | Dec 13, 4:02 pm EST | Bernard RavinaChief Medical Officer | 5,490 | $13.63 | $74,829 | 10,983 | −33.3% | plan? |
| Nov 10, 2017 SForm 4 → | Nov 13, 4:15 pm EST | Bernard RavinaChief Medical Officer | 5,490 | $13.26 | $72,797 | 16,473 | −25.0% | plan? |
| Oct 10, 2017 SForm 4 → | Oct 12, 7:28 pm EDT | Bernard RavinaChief Medical Officer | 10,980 | $20.33 | $223,223 | 21,963 | −33.3% | plan? |
| Sep 5, 2017 SForm 4 → | Sep 6, 4:38 pm EDT | Bernard RavinaChief Medical Officer | 5,490 | $10.00 | $54,900 | 17,157 | −24.2% | plan? |
| Jul 20, 2017 SForm 4 → | Sep 13, 5:23 pm EDT | Bernard RavinaChief Medical Officer | 16,470 | $12.87 | $211,914 | 32,943 | −33.3% | plan? late |
| Apr 12, 2017 JForm 4 → | Apr 14, 4:00 pm EDT | Third Rock Ventures III, L.P. +410% Owner | 920,000 | — | — | 9,391,176 | — | plan? |
| Apr 12, 2017 JForm 4 → | Apr 14, 4:00 pm EDT | Mark J LevinDirector, 10% Owner | 920,000 | — | — | 9,391,176 | — | plan? |
| Dec 19, 2016 JForm 4 → | Dec 21, 5:51 pm EST | Mark J LevinDirector, 10% Owner | 750,000 | — | — | 10,311,176 | — | plan? |
| Dec 19, 2016 JForm 4 → | Dec 21, 5:49 pm EST | Third Rock Ventures III, L.P. +410% Owner | 750,000 | — | — | 10,311,176 | — | plan? |
| Jan 14, 2016 PForm 4 → | Jan 15, 5:01 pm EST | Steven M PaulPresident and CEO, Director | 10,000 | $14.07 | $140,690 | 872,351 | +1.16% | plan? |
| Nov 16, 2015 CForm 4 → | Nov 18, 9:03 pm EST | Hadley Harbor Master Investors (Cayman) L.P.10% Owner | 470,588 | — | — | 470,588 | — | plan? |
| Nov 16, 2015 CForm 4 → | Nov 18, 4:33 pm EST | Third Rock Ventures III, L.P. +410% Owner | 10,588,235 | — | — | 11,061,176 | — | plan? |
| Nov 16, 2015 CForm 4 → | Nov 18, 4:04 pm EST | Mark J LevinDirector | 10,588,235 | — | — | 11,061,176 | — | plan? |
| Nov 16, 2015 PForm 4 → | Nov 18, 2:26 pm EST | SanofiOther | 125,000 | $14.00 | $1,750,000 | 2,477,941 | +5.31% | plan? |
| Nov 10, 2015 CForm 4 → | Nov 18, 2:26 pm EST | SanofiOther | 2,352,941 | — | — | 2,352,941 | — | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 9, 2026 AForm 4 → | Jun 11, 4:05 pm EDT | George A ScangosDirector | 30,000 | — | — | 30,000 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:05 pm EDT | Catherine J MackeyDirector | 30,000 | — | — | 30,000 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:04 pm EDT | Steven HymanDirector | 30,000 | — | — | — | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:04 pm EDT | Nancy VitaleDirector | 30,000 | — | — | 30,000 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:03 pm EDT | Michael J HigginsDirector | 30,000 | — | — | 30,000 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:02 pm EDT | Jude OnyiaDirector | 30,000 | — | — | 30,000 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:02 pm EDT | James A GeraghtyDirector | 30,000 | — | — | 30,000 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:01 pm EDT | Grace ColonDirector | 30,000 | — | — | — | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:01 pm EDT | Glenn PierceDirector | 30,000 | — | — | 30,000 | — | |
| Jan 11, 2019 AForm 4 → | Jan 17, 9:05 pm EST | Andre TurennePresident & CEO, Director | 192,500 | — | — | 192,500 | — | late |
| Jan 11, 2019 AForm 4 → | Jan 17, 8:51 pm EST | Dinah Sah Ph.D.Chief Scientific Officer | 50,000 | — | — | 50,000 | — | late |
| Jan 11, 2019 AForm 4 → | Jan 17, 8:44 pm EST | Matthew P. OttmerChief Operating Officer | 60,000 | — | — | 60,000 | — | late |
| Jan 11, 2019 AForm 4 → | Jan 17, 8:41 pm EST | Allison DorvalChief Financial Officer | 50,000 | — | — | 50,000 | — | late |
| Nov 7, 2018 AForm 4 → | Nov 9, 4:20 pm EST | Allison DorvalChief Financial Officer | 45,000 | — | — | 45,000 | — | |
| Jul 16, 2018 AForm 4 → | Jul 18, 5:56 pm EDT | Andre TurennePresident & CEO, Director | 650,000 | — | — | 650,000 | — | |
| Jun 14, 2018 AForm 4 → | Jun 18, 8:50 pm EDT | Glenn PierceDirector | 15,000 | — | — | 15,000 | — | |
| Jun 14, 2018 AForm 4 → | Jun 18, 8:49 pm EDT | Michael J HigginsDirector | 15,000 | — | — | 15,000 | — | |
| Jun 14, 2018 AForm 4 → | Jun 18, 8:48 pm EDT | Mark J LevinDirector | 15,000 | — | — | 15,000 | — | |
| Jun 14, 2018 AForm 4 → | Jun 18, 8:48 pm EDT | Steven HymanDirector | 15,000 | — | — | 15,000 | — | |
| Jun 14, 2018 AForm 4 → | Jun 18, 8:47 pm EDT | Wendy L DixonDirector | 15,000 | — | — | 15,000 | — | |
| Jun 14, 2018 AForm 4 → | Jun 18, 8:46 pm EDT | James A GeraghtyDirector | 15,000 | — | — | 15,000 | — | |
| Jun 14, 2018 AForm 4 → | Jun 18, 8:44 pm EDT | Perry A KarsenDirector | 15,000 | — | — | 15,000 | — | |
| Mar 22, 2018 MForm 4 → | Mar 26, 4:02 pm EDT | Jane HendersonSr. V.P. & CFO, Corp. Dev. | 31,100 | — | — | 165,584 | — | |
| Mar 16, 2018 MForm 4 → | Mar 20, 5:43 pm EDT | Jane HendersonCFO & SVP, Corp. Dev. | 17,316 | — | — | 196,684 | — | |
| Mar 7, 2018 AForm 4 → | Mar 9, 7:12 pm EST | Steven M PaulChief Executive Officer, Director | 110,000 | — | — | 110,000 | — | |
| Mar 7, 2018 AForm 4 → | Mar 9, 7:12 pm EST | Matthew P. OttmerChief Operating Officer | 65,000 | — | — | 65,000 | — | |
| Mar 7, 2018 AForm 4 → | Mar 9, 7:12 pm EST | Dinah Sah Ph.D.Chief Scientific Officer | 65,000 | — | — | 65,000 | — | |
| Mar 7, 2018 AForm 4 → | Mar 9, 7:11 pm EST | Bernard RavinaChief Medical Officer | 65,000 | — | — | 65,000 | — | |
| Mar 7, 2018 AForm 4 → | Mar 9, 7:11 pm EST | Jane HendersonSr. V.P. & CFO | 65,000 | — | — | 65,000 | — | |
| Feb 27, 2018 MForm 4 → | Mar 1, 6:00 pm EST | Dinah Sah Ph.D.Chief Scientific Officer | 15,623 | — | — | 60,937 | — | |
| Sep 14, 2017 AForm 4 → | Sep 18, 4:13 pm EDT | Matthew P. OttmerChief Operating Officer | 250,000 | — | — | 250,000 | — | |
| Jun 29, 2017 AForm 4 → | Jun 30, 4:03 pm EDT | Mark J LevinDirector | 15,000 | — | — | 15,000 | — | |
| Jun 29, 2017 AForm 4 → | Jun 30, 4:03 pm EDT | Wendy L DixonDirector | 15,000 | — | — | 15,000 | — | |
| Jun 29, 2017 AForm 4 → | Jun 30, 4:02 pm EDT | Michael J HigginsDirector | 15,000 | — | — | 15,000 | — | |
| Jun 29, 2017 AForm 4 → | Jun 30, 4:02 pm EDT | James A GeraghtyDirector | 15,000 | — | — | 15,000 | — | |
| Jun 29, 2017 AForm 4 → | Jun 30, 4:02 pm EDT | Steven HymanDirector | 15,000 | — | — | 15,000 | — | |
| Jun 29, 2017 AForm 4 → | Jun 30, 4:02 pm EDT | Perry A KarsenDirector | 15,000 | — | — | 15,000 | — | |
| Jun 29, 2017 AForm 4 → | Jun 30, 4:02 pm EDT | Glenn PierceDirector | 15,000 | — | — | 15,000 | — | |
| Feb 8, 2017 AForm 4 → | Feb 10, 4:01 pm EST | Steven M PaulPresident and CEO, Director | 240,000 | $11.83 | $2,839,200 | 240,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 5:26 pm EST | Jane HendersonSr. V.P. & CFO | 214,000 | — | — | 214,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 5:26 pm EST | Glenn PierceDirector | 30,000 | — | — | 30,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 5:25 pm EST | Wendy L DixonDirector | 30,000 | — | — | 30,000 | — | |
| Jun 15, 2016 AForm 4 → | Jun 20, 4:05 pm EDT | Michael J HigginsDirector | 15,000 | — | — | 15,000 | — | late |
| Jun 15, 2016 AForm 4 → | Jun 17, 7:00 pm EDT | James A GeraghtyDirector | 15,000 | — | — | 15,000 | — | |
| Jun 15, 2016 AForm 4 → | Jun 17, 7:00 pm EDT | Mark J LevinDirector | 15,000 | — | — | 15,000 | — | |
| Jun 15, 2016 AForm 4 → | Jun 17, 7:00 pm EDT | Perry A KarsenDirector | 15,000 | — | — | 15,000 | — | |
| Jun 15, 2016 AForm 4 → | Jun 17, 6:59 pm EDT | Steven HymanDirector | 15,000 | — | — | 15,000 | — | |
| Feb 1, 2016 AForm 4 → | Feb 2, 4:03 pm EST | Steven M PaulPresident and CEO, Director | 200,000 | $11.09 | $2,218,000 | 200,000 | — | |
| Feb 1, 2016 AForm 4 → | Feb 2, 4:03 pm EST | Jeff GoaterChief Financial Officer | 65,000 | $11.09 | $720,850 | 65,000 | — | |
| Nov 16, 2015 CForm 4 → | Nov 18, 9:03 pm EST | Hadley Harbor Master Investors (Cayman) L.P.10% Owner | 2,000,000 | — | — | 0 | — | |
| Nov 16, 2015 CForm 4 → | Nov 18, 4:33 pm EST | Third Rock Ventures III, L.P. +410% Owner | 45,000,000 | — | — | 0 | — | |
| Nov 16, 2015 CForm 4 → | Nov 18, 4:04 pm EST | Mark J LevinDirector | 45,000,000 | — | — | 0 | — | |
| Nov 10, 2015 CForm 4 → | Nov 18, 2:26 pm EST | SanofiOther | 10,000,000 | — | — | 0 | — | late |
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.